These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37359758)

  • 1. The Role of EU Trade Secrets Law in the Data Economy: An Empirical Analysis.
    Aplin T; Radauer A; Bader MA; Searle N
    IIC Int Rev Ind Prop Copyr Law; 2023 May; ():1-33. PubMed ID: 37359758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal 3D printing: Patent law, trade secrets, and additive manufacturing.
    Rimmer M
    Front Res Metr Anal; 2022; 7():958761. PubMed ID: 36118015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legal regulation of the production and trade of medical devices and medical equipment in the EU and US: experience for Ukraine.
    Pashkov V; Kotvitska A; Harkusha A
    Wiad Lek; 2017; 70(3 pt 2):614-618. PubMed ID: 28713093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances towards circular economy policies in the EU: The new Ecodesign regulation of enterprise servers.
    Talens Peiró L; Polverini D; Ardente F; Mathieux F
    Resour Conserv Recycl; 2020 Mar; 154():104426. PubMed ID: 32127729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advertising of medical devices: foreign experience and Ukrainian practice.
    Pashkov V; Harkusha A; Bytiak O
    Wiad Lek; 2017; 70(3 pt 1):456-461. PubMed ID: 28711887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health, alcohol and EU law: understanding the impact of European single market law on alcohol policies.
    Baumberg B; Anderson P
    Eur J Public Health; 2008 Aug; 18(4):392-8. PubMed ID: 18467360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A concise framework to facilitate open COVID pledge of non-disclosed technologies: In terms of non-disclosed patent applications and trade secrets.
    Wang RL; Shen CL; Wu TC; Hsiao WW
    J Formos Med Assoc; 2022 Aug; 121(8):1425-1430. PubMed ID: 34756502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Support for international trade law: The US and the EU compared.
    Eckhardt J; Elsig M
    Int J Const Law; 2015 Oct; 13(4):966-986. PubMed ID: 27867316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does international trade and investment liberalization facilitate corporate power in nutrition and alcohol policymaking? Applying an integrated political economy and power analysis approach to a case study of South Africa.
    Milsom P; Smith R; Modisenyane SM; Walls H
    Global Health; 2022 Mar; 18(1):32. PubMed ID: 35279184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juridification, medicalisation, and the impact of EU Law: patient mobility and the allocation of scarce NHS resources.
    Veitch K
    Med Law Rev; 2012; 20(3):362-98. PubMed ID: 22535326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agenda setting and socially contentious policies: Ethiopia's 2005 reform of its law on abortion.
    Holcombe SJ; Kidanemariam Gebru S
    Reprod Health; 2022 Jun; 19(Suppl 1):218. PubMed ID: 35698196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copyright and Digital Teaching Exceptions in the EU: Legislative Developments and Implementation Models of Art. 5 CDSM Directive.
    Priora G; Jütte BJ; Mezei P
    IIC Int Rev Ind Prop Copyr Law; 2022; 53(4):543-566. PubMed ID: 35399993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enforceability of non-compete agreements in medical practice: between law and ethics.
    Pashkov VM; Harkusha AО
    Wiad Lek; 2019; 72(12 cz 2):2421-2426. PubMed ID: 32124763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protecting essential information about genetic variants as trade secrets: a problem for public policy?
    Juergens AK; Francis LP
    J Law Biosci; 2018 Dec; 5(3):682-705. PubMed ID: 31143458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solidarity as a Political Determinant of Health: Insights from EU Competition Policy.
    Guy M
    J Health Polit Policy Law; 2024 Apr; ():. PubMed ID: 38567773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [More transparency in clinical research: How are the new transparency regulations assessed from the perspective of the pharmaceutical industry?].
    Wachenhausen H; Peters J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Jan; 66(1):60-67. PubMed ID: 36542105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health impact assessment: assessing opportunities and barriers to intersectoral health improvement in an expanded European Union.
    Lock K; McKee M
    J Epidemiol Community Health; 2005 May; 59(5):356-60. PubMed ID: 15831682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do supranational EU institutions make a difference? EU asylum law before and after 'communitarization'.
    Ripoll Servent A; Trauner F
    J Eur Public Policy; 2014 Sep; 21(8):1142-1162. PubMed ID: 26924934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Poland's agri-food industry gain comparative advantage in trade with non-EU countries? Evidence from the transatlantic market.
    Pawlak K; Smutka L
    PLoS One; 2022; 17(9):e0274692. PubMed ID: 36112585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotechnology as an intellectual property.
    Adler RG
    Science; 1984 Apr; 224(4647):357-63. PubMed ID: 6584975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.